In this Backstory, we narrate our journey in establishing a multidisciplinary team for sarcoma research and uncovering vulnerabilities in chondrosarcoma cells associated with their NAD dependencies for survival. Our findings hold promise for exploitation, yielding a synergistic cytotoxic effect when combined with systemic therapy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10829863 | PMC |
http://dx.doi.org/10.1016/j.xcrm.2023.101385 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!